Proteros and SUPERGEN enter into an integrated lead discovery agreement

07-Feb-2011 - Germany

Proteros Biostructures GmbH announced that it has entered into an agreement with SuperGen Inc., under which Proteros will collaborate on the discovery of small molecule lead compounds against a specific target of interest. Under the agreement, Proteros will deploy its integrated lead discovery platform that seamlessly links structural biology, screening of a tailor-made compound and fragment library, compound profiling and medicinal chemistry activities aimed at rapid fragment evolution and lead finding.

Other news from the department research and development

Most read news

More news from our other portals

Fighting cancer: latest developments and advances